• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞浸润预示着人类尤文肉瘤预后不良。

Macrophage infiltration predicts a poor prognosis for human ewing sarcoma.

机构信息

Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

出版信息

Am J Pathol. 2011 Sep;179(3):1157-70. doi: 10.1016/j.ajpath.2011.05.034. Epub 2011 Jul 21.

DOI:10.1016/j.ajpath.2011.05.034
PMID:21771572
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3157220/
Abstract

Ewing sarcoma-primitive neuroectodermal tumor (EWS) is associated with the most unfavorable prognosis of all primary musculoskeletal tumors. The objective of the present study was to investigate whether tumor-associated macrophages (TAMs) affect the development of EWS. TAMs were isolated from mouse xenografts using CD11b magnetic beads and examined for their cytokine expression and osteoclastic differentiation. To evaluate the role of TAMs in xenograft formation, liposome-encapsulated clodronate was used to deplete TAMs in mice. Macrophage infiltration and tumor microvascular density were histologically evaluated in 41 patients with EWS, and association with prognosis was examined using Kaplan-Meier survival analysis. In mouse EWS xenografts, TAMs expressed higher concentrations of cytokines including interleukin-6, keratinocyte-derived chemokine, and monocyte chemotactic protein-1. TAMs were more capable than normal monocytes of differentiating into tartrate-resistant acid phosphatase-positive giant cells. Depleting macrophages using liposome-encapsulated clodronate significantly inhibited development of EWS xenografts. In human EWS samples, higher levels of CD68-positive macrophages were associated with poorer overall survival. In addition, enhanced vascularity, increase in the amount of C-reactive protein, and higher white blood cell counts were also associated with poor prognosis and macrophage infiltration. TAMs seem to enhance the progression of EWS by stimulating both angiogenesis and osteoclastogenesis. Further investigation of the behavior of TAMs may lead to development of biologically targeted therapies for EWS.

摘要

尤因肉瘤-原始神经外胚层肿瘤(EWS)与所有原发性肌肉骨骼肿瘤中最不利的预后相关。本研究的目的是探讨肿瘤相关巨噬细胞(TAMs)是否影响 EWS 的发展。使用 CD11b 磁珠从小鼠异种移植物中分离 TAMs,并检查其细胞因子表达和破骨细胞分化。为了评估 TAMs 在异种移植物形成中的作用,使用脂质体包裹的氯膦酸盐在小鼠中耗尽 TAMs。在 41 例 EWS 患者中评估 TAMs 浸润和肿瘤微血管密度,并使用 Kaplan-Meier 生存分析检查与预后的关联。在小鼠 EWS 异种移植物中,TAMs 表达更高浓度的细胞因子,包括白细胞介素-6、角质细胞衍生趋化因子和单核细胞趋化蛋白-1。TAMs 比正常单核细胞更能分化为抗酒石酸酸性磷酸酶阳性巨细胞。使用脂质体包裹的氯膦酸盐耗尽巨噬细胞可显著抑制 EWS 异种移植物的发展。在人类 EWS 样本中,CD68 阳性巨噬细胞水平较高与总生存率较差相关。此外,血管生成增加、C 反应蛋白增加和白细胞计数增加也与预后不良和巨噬细胞浸润相关。TAMs 通过刺激血管生成和破骨细胞生成似乎增强了 EWS 的进展。进一步研究 TAMs 的行为可能会导致开发针对 EWS 的生物靶向治疗。

相似文献

1
Macrophage infiltration predicts a poor prognosis for human ewing sarcoma.巨噬细胞浸润预示着人类尤文肉瘤预后不良。
Am J Pathol. 2011 Sep;179(3):1157-70. doi: 10.1016/j.ajpath.2011.05.034. Epub 2011 Jul 21.
2
MiR-708-5p is inversely associated with EWS/FLI1 Ewing sarcoma but does not represent a prognostic predictor.微小RNA-708-5p与尤因肉瘤中的EWS/FLI1呈负相关,但并非预后预测指标。
Cancer Genet. 2019 Jan;230:21-27. doi: 10.1016/j.cancergen.2018.11.003. Epub 2018 Nov 13.
3
High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.尤因肉瘤细胞中的高通量RNA干扰筛选确定富含亮氨酸重复序列和WD重复结构域1(LRWD1)是EWS-FLI1驱动的细胞活力的调节因子。
Gene. 2017 Jan 5;596:137-146. doi: 10.1016/j.gene.2016.10.021. Epub 2016 Oct 17.
4
Clinical features and outcomes in patients with secondary Ewing sarcoma.继发性尤文肉瘤患者的临床特征和结局。
Pediatr Blood Cancer. 2013 Apr;60(4):611-5. doi: 10.1002/pbc.24251. Epub 2012 Jul 27.
5
Clinicopathological correlation of tumor-associated macrophages in Ewing sarcoma.尤因肉瘤中肿瘤相关巨噬细胞的临床病理相关性
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018 Mar;162(1):54-60. doi: 10.5507/bp.2017.049. Epub 2017 Nov 21.
6
Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.靶向 EWS/Fli-1 断点的合成 siRNA 抑制小鼠模型中尤文肉瘤异种移植物的生长。
Int J Cancer. 2011 Jan 1;128(1):216-26. doi: 10.1002/ijc.25564.
7
Absence of detectable EWS/FLI1 expression after therapy-induced neural differentiation in Ewing sarcoma.尤因肉瘤经治疗诱导神经分化后未检测到EWS/FLI1表达。
Hum Pathol. 1998 Mar;29(3):289-94. doi: 10.1016/s0046-8177(98)90049-1.
8
Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.尤因肉瘤患者的神经肽Y系统水平和二肽基肽酶活性——与肿瘤表型和生存的关联
Cancer. 2015 Mar 1;121(5):697-707. doi: 10.1002/cncr.29090. Epub 2014 Nov 11.
9
Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma.尤因肉瘤中破骨细胞形成的细胞和体液机制。
Br J Cancer. 2007 Jun 4;96(11):1716-22. doi: 10.1038/sj.bjc.6603774. Epub 2007 May 29.
10
FOXM1 is an oncogenic mediator in Ewing Sarcoma.FOXM1 是尤文肉瘤中的致癌介质。
PLoS One. 2013;8(1):e54556. doi: 10.1371/journal.pone.0054556. Epub 2013 Jan 24.

引用本文的文献

1
A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcoma.一项关于CSF1R抑制剂维姆塞尔替尼联合PD-L1抑制剂阿维鲁单抗治疗晚期肉瘤患者的I期研究。
ESMO Open. 2025 Jul 25;10(8):105522. doi: 10.1016/j.esmoop.2025.105522.
2
Harnessing the immune responses: a new frontier in Ewing sarcoma treatment.利用免疫反应:尤因肉瘤治疗的新前沿。
Med Oncol. 2025 Jun 27;42(8):291. doi: 10.1007/s12032-025-02848-5.
3
Tumor-associated stroma shapes the spatial tumor immune microenvironment of primary Ewing sarcomas.肿瘤相关基质塑造了原发性尤因肉瘤的空间肿瘤免疫微环境。
bioRxiv. 2025 Feb 6:2025.01.31.635996. doi: 10.1101/2025.01.31.635996.
4
The ubiquitin ligase Pellino1 targets STAT3 to regulate macrophage-mediated inflammation and tumor development.泛素连接酶Pellino1靶向信号转导和转录激活因子3(STAT3)以调节巨噬细胞介导的炎症和肿瘤发展。
Nat Commun. 2025 Feb 1;16(1):1256. doi: 10.1038/s41467-025-56440-6.
5
Macrophages in tumor cell migration and metastasis.肿瘤细胞迁移和转移中的巨噬细胞。
Front Immunol. 2024 Nov 1;15:1494462. doi: 10.3389/fimmu.2024.1494462. eCollection 2024.
6
Circumventing resistance within the Ewing sarcoma microenvironment by combinatorial innate immunotherapy.通过组合性先天免疫疗法绕过尤文肉瘤微环境中的耐药性。
J Immunother Cancer. 2024 Sep 12;12(9):e009726. doi: 10.1136/jitc-2024-009726.
7
Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning "Two Keys" simultaneously.组合巨噬细胞诱导固有免疫疗法治疗尤文肉瘤:同时“双管齐下”。
J Exp Clin Cancer Res. 2024 Jul 11;43(1):193. doi: 10.1186/s13046-024-03093-w.
8
Anti-CD99 Antibody Therapy Triggers Macrophage-Dependent Ewing Cell Death In Vitro and Myeloid Cell Recruitment In Vivo.抗CD99抗体疗法在体外引发巨噬细胞依赖性尤因细胞死亡并在体内募集髓样细胞。
Antibodies (Basel). 2024 Mar 18;13(1):24. doi: 10.3390/antib13010024.
9
Branched-chain keto acids promote an immune-suppressive and neurodegenerative microenvironment in leptomeningeal disease.支链酮酸在柔脑膜疾病中促进免疫抑制和神经退行性微环境。
bioRxiv. 2023 Dec 18:2023.12.18.572239. doi: 10.1101/2023.12.18.572239.
10
Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages.CD99 的激活在尤文肉瘤和巨噬细胞中引发了不同的程序。
Cancer Immunol Res. 2024 Feb 2;12(2):247-260. doi: 10.1158/2326-6066.CIR-23-0440.

本文引用的文献

1
Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents.肿瘤浸润巨噬细胞与高级别骨肉瘤的转移抑制相关:使用巨噬细胞激活剂治疗的理论基础。
Clin Cancer Res. 2011 Apr 15;17(8):2110-9. doi: 10.1158/1078-0432.CCR-10-2047. Epub 2011 Mar 3.
2
Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.促炎趋化因子-趋化因子受体相互作用在尤文肉瘤微环境中决定 CD8(+) T 淋巴细胞浸润并影响肿瘤进展。
J Pathol. 2011 Feb;223(3):347-57. doi: 10.1002/path.2819. Epub 2010 Dec 10.
3
Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma.内皮糖蛋白在尤文肉瘤和黑色素瘤肿瘤细胞可塑性中的关键作用。
Oncogene. 2011 Jan 20;30(3):334-45. doi: 10.1038/onc.2010.418. Epub 2010 Sep 20.
4
Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1-PI3K-Rac1 pathway.骨微环境中的碱性成纤维细胞生长因子通过激活 FGFR1-PI3K-Rac1 通路增强尤文氏肉瘤家族肿瘤的细胞迁移和侵袭。
Br J Cancer. 2010 Jul 27;103(3):370-81. doi: 10.1038/sj.bjc.6605775. Epub 2010 Jul 6.
5
An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis.一种抗菌肽通过趋化因子受体 CCR2 调节肿瘤相关巨噬细胞的迁移,为肿瘤发生提供了模型。
PLoS One. 2010 Jun 8;5(6):e10993. doi: 10.1371/journal.pone.0010993.
6
Clinicopathological significance of cell cycle regulation markers in a large series of genetically confirmed Ewing's sarcoma family of tumors.在一大系列经基因确认的尤文氏肉瘤家族肿瘤中,细胞周期调节标志物的临床病理意义。
Int J Cancer. 2011 Mar 1;128(5):1139-50. doi: 10.1002/ijc.25424.
7
Expression and prognostic significance of osteopontin and caspase-3 in hepatocellular carcinoma patients after curative resection.骨桥蛋白和半胱氨酸天冬氨酸蛋白酶-3 在肝癌患者根治性切除术后的表达及预后意义。
Cancer Sci. 2010 May;101(5):1314-9. doi: 10.1111/j.1349-7006.2010.01524.x. Epub 2010 Feb 5.
8
Hallmarks of cancer: interactions with the tumor stroma.癌症的标志:与肿瘤基质的相互作用。
Exp Cell Res. 2010 May 1;316(8):1324-31. doi: 10.1016/j.yexcr.2010.02.045. Epub 2010 Mar 6.
9
Ewing sarcoma family of tumors.尤文氏肉瘤家族肿瘤。
J Am Acad Orthop Surg. 2010 Feb;18(2):94-107. doi: 10.5435/00124635-201002000-00004.
10
VEGF165 promotes the osteolytic bone destruction of ewing's sarcoma tumors by upregulating RANKL.VEGF165 通过上调 RANKL 促进尤因肉瘤肿瘤的溶骨性骨破坏。
Oncol Res. 2009;18(2-3):117-25. doi: 10.3727/096504009789954627.